xenografts

Related by string. xenograft * * xenograft models . xenograft model . human tumor xenografts . xenograft implants . xenograft tumors . xenograft tumor models . animal xenograft tissue . tumor xenografts . mouse xenograft models . human tumor xenograft . tumor xenograft models . mouse xenograft model . xenograft tissue . patient derived xenografts . animal xenograft models *

Related by context. All words. (Click for frequent words.) 72 tumor xenografts 72 MDA MB 72 xenograft tumors 71 syngeneic 71 xenograft models 71 colon carcinoma 71 orthotopic 69 murine 69 xenograft 69 tumorigenicity 68 xenograft model 68 hepatoma 68 transgene expression 67 transfected 67 peripheral blood mononuclear 67 hTERT 67 transfected cells 67 cisplatin resistant 67 mouse xenograft models 67 cytotoxicity 67 NOD SCID mice 66 prostate carcinoma 66 HepG2 cells 66 carcinoembryonic antigen 66 C#BL 6 mice 66 radiosensitivity 66 EpCAM 66 mRNA expression 66 tumor xenograft models 66 alveolar epithelial cells 66 immunohistochemical analysis 66 prostate epithelial cells 66 adenoviral 66 EGFP 65 pancreatic adenocarcinoma 65 lymphoid cells 65 breast carcinomas 65 cells transfected 65 cells overexpressing 65 immunostaining 65 immunohistochemical staining 65 androgen receptor AR 65 immunoreactivity 65 antisense inhibition 65 mouse xenograft 65 db db mice 65 Immunohistochemical analysis 65 induced apoptosis 65 MDCK cells 65 Immunohistochemical staining 65 ovarian carcinoma 65 PC3 cells 65 androgen independent 64 bleomycin 64 immunodeficient mice 64 LNCaP cells 64 miR #a [001] 64 Xenograft 64 breast carcinoma 64 Flt3 64 constitutively active 64 inhibited tumor 64 wildtype 64 WT1 64 tumor antigen 64 TGF beta1 64 HepG2 64 trophoblast cells 64 PBMCs 64 immunohistochemical 64 athymic mice 64 MEFs 64 gemcitabine carboplatin 64 pulmonary metastases 63 FLT3 63 human tumor xenografts 63 bronchial epithelial cells 63 ERalpha 63 survivin 63 HER2/neu 63 cytokeratin 63 E#F# 63 RRM1 63 annexin V 63 interferon IFN 63 cytotoxicity assays 63 EGFR HER2 63 potently inhibited 63 colorectal carcinoma 63 CD#b 63 effector function 63 papillomas 63 neuroblastoma cells 63 TIMP 63 pegylated liposomal doxorubicin 63 EGFRvIII 63 EGFR protein 63 colorectal tumor 63 haematopoietic 63 Preclinical studies 63 MAPK pathway 63 castrate resistant 63 Overexpression 63 IFN gamma 63 PTHrP 63 inhibitory effects 63 Endometrial 63 malignant prostate 63 TNFa 63 epithelial tumors 63 pro angiogenic 63 constitutively expressed 63 CHO cells 62 potent antitumor activity 62 overexpressing 62 vitro studies 62 transgenic mice 62 embryonal carcinoma 62 HER2 receptor 62 fibroblast 62 PC# cells 62 CDK4 62 nanomolar 62 c MYC 62 breast epithelial cells 62 BALB c mice 62 coexpression 62 vitro experiments 62 ERK1 2 62 BRAF V#E mutation 62 splenocytes 62 RANTES 62 GHRH 62 activin 62 ENMD # 62 miRNA expression 62 proto oncogene 62 lymph node metastasis 62 experimental autoimmune encephalomyelitis 62 induces apoptosis 62 CD# CD# 62 squamous cell carcinoma SCC 62 HCV replicon 62 ErbB2 62 HDACi 62 leukemic cell 62 vitro cytotoxicity 62 urothelial carcinoma 62 TIMP 1 62 deacetylation 62 sarcomatoid 62 intraperitoneal injection 62 antitumor efficacy 62 TNF α 62 immunofluorescence 62 XL# inhibits 62 antigenic epitopes 62 hepatocyte 62 H#K#me# 62 histopathologic examination 62 demonstrated antitumor activity 62 miR #a [002] 61 osteoblastic 61 Eg5 61 qRT PCR 61 chemoresistant 61 metaplasia 61 tumoral 61 N cadherin 61 cellularity 61 ERBB2 61 Rap1 61 uPAR 61 immunoblotting 61 myeloma cells 61 immunofluorescence staining 61 virulence genes 61 CCR7 61 cynomolgus monkeys 61 TRAIL induced apoptosis 61 iNOS 61 homozygotes 61 castration resistant 61 HBV replication 61 cyclin E 61 CD#c 61 HEK# cells 61 anti CD3 61 peptide antigens 61 CD# expression [001] 61 Akt activation 61 null mice 61 mucinous 61 transgenic rats 61 Annexin V 61 Leydig cell 61 nucleolin 61 intratumoral injection 61 VSV G 61 antiproliferative effects 61 supernatants 61 histone deacetylase inhibitor 61 thymidylate synthase TS 61 CDK inhibitor 61 p# INK4a 61 leukemic stem cells 61 5alpha reductase 61 pDC 61 vivo 61 HIF 1α 61 differentially expressed genes 61 PCa 61 heterozygotes 61 SCID mice 61 β catenin 61 vimentin 61 precursor lesions 61 dinucleotide 61 adrenocortical 61 colorectal adenocarcinoma 61 DLC1 61 lysates 61 thymidine 61 keratinocyte 61 neuroblastoma tumors 61 Jurkat cells 61 interleukin IL -# 61 GBM tumors 61 CXCR4 61 NF kappaB activation 61 isoform 61 SPINK1 61 explants 61 caveolin 1 61 glioblastoma cells 61 androgen dependent 61 HIF 1alpha 61 bispecific antibody 61 PDGFR 61 VEGFR2 61 K ras mutations 61 flavopiridol 61 heterologous 60 microRNA miR 60 basal cell carcinoma BCC 60 biodistribution 60 IFN alpha 60 Activating mutations 60 tumor infiltrating lymphocytes 60 Western blotting 60 antiproliferative activity 60 ERCC1 60 transgenic mice expressing 60 iPSC 60 CD# expressing 60 ectopic expression 60 ERK signaling 60 Gleevec resistant 60 HER2 neu 60 GSTP1 60 lung metastases 60 hA# 60 CD4 + CD# 60 CEACAM1 60 bioluminescence imaging 60 GFAP 60 murine model 60 phospho 60 melanoma tumors 60 IgG1 60 E cadherin expression 60 substrate specificity 60 proteolytic cleavage 60 papillary 60 BALB c 60 AMACR 60 potent inhibition 60 quantitative RT PCR 60 IFN α 60 TGF ß 60 TRAIL receptors 60 antitumor activity 60 hepatocellular carcinomas 60 p# Shc 60 CD8 + 60 depsipeptide 60 mutational status 60 sequence homology 60 osteosarcomas 60 MTT assay 60 triphendiol 60 trophoblasts 60 humoral immune responses 60 osteogenic 60 amino terminal 60 P selectin 60 inducible nitric oxide synthase 60 MCF7 60 mutated KRAS 60 immunocytochemistry 60 estrogen receptor ER 60 transduced 60 downregulated 60 Mesothelin 60 papillary thyroid carcinoma 60 NFkB 60 M1 muscarinic 60 Aplidin 60 milatuzumab 60 lung carcinomas 60 Sertoli cell 60 K#R [002] 60 protein tyrosine phosphatase 60 occludin 60 thyroid carcinoma 60 EGFr 60 isotypes 60 5FU 60 somatostatin 60 CD# + [001] 60 CCR9 60 ß1 60 CD# [002] 60 p#Kip# 60 normal karyotype 60 selective agonist 60 fibroblast cells 60 neoplastic cells 60 TTR gene 60 pDCs 60 glioma cells 60 transcriptionally 60 tyrosine phosphorylation 60 Cre recombinase 60 HGPIN 60 activated lymphocytes 60 unmutated 59 TNFalpha 59 potent inhibitory 59 ^ sup #m 59 transgenic mouse model 59 replicon 59 SOCS3 59 NKX#.# 59 SIRT2 59 lobular 59 radiolabeled 59 Rab5 59 FGFR4 59 miR #b [001] 59 pleomorphic 59 bone marrow stromal cells 59 neoplastic 59 Foxp3 59 tumorigenic 59 effector memory 59 CCL# 59 Kupffer cells 59 ribonuclease 59 papillary renal cell carcinoma 59 fluoropyrimidine 59 murine models 59 germline 59 osteoblast 59 neuropilin 59 neoplastic lesions 59 antiapoptotic 59 recombinants 59 PGCs 59 promoter methylation 59 mRNA transcripts 59 thymidine kinase 59 deficient mice 59 splice variants 59 oncoproteins 59 KRAS wild 59 Jhdm2a 59 MT1 MMP 59 vesicular stomatitis virus 59 V#F mutation 59 chemo resistant 59 etoposide 59 imetelstat 59 overexpression 59 matrix metalloproteinases 59 potently inhibits 59 IFN beta 59 effector functions 59 nonmetastatic 59 PEGPH# 59 EGF receptor 59 missense mutations 59 P cadherin 59 acinar 59 metastatic neuroendocrine tumors 59 Leydig cells 59 LHRH receptor positive 59 somatostatin receptors 59 neutralizing antibody responses 59 β1 59 poly ADP ribose polymerase 59 p#NTR 59 tumor regressions 59 skeletal metastases 59 FGFR3 59 murine monoclonal antibody 59 pathophysiological effects 59 HER2 expression 59 #F FDG 59 immunohistochemistry IHC 59 TGF alpha 59 neovascularization 59 Lodamin 59 IL 1β 59 Tie2 59 suppressor cells 59 eNOS 59 inhibitory activity 59 hematopoietic progenitor cells 59 proapoptotic 59 microRNA expression 59 microsatellite instability 59 immunized mice 59 glomerular 59 HBx 59 cervical carcinoma 59 TRAIL R2 59 CCR2 59 LRAT 59 ER alpha 59 HER-2/neu 59 cells hESCs 59 cellular prion protein 59 telomerase reverse transcriptase 59 preclinical efficacy 59 IGF 1R 59 mesothelin 59 mice lacking 59 microglial activation 59 extracellular domain 59 EGFR receptor 59 TGF ß1 59 adenocarcinomas 59 T#I [002] 59 N Myc 59 Kahalalide F 59 gemcitabine cisplatin 59 EphB4 59 ErbB2 positive 59 gene amplification 59 histological subtype 59 daunorubicin 59 oncogenic transformation 59 ex vivo 59 ZFN modified 59 pancreatic endocrine 59 CD1d 59 methylated DNA 59 mTOR inhibitors 59 polyclonal 59 CLL cells 59 constitutively 59 histologically 59 MMP9 59 renal tumors 59 cathepsin B 59 PrPSc 59 MMP2 59 hyperplastic 59 Trp p8 59 PTPN# 59 homodimer 59 NFκB 59 anti angiogenic agent 59 anti proliferative 59 luciferase reporter 59 FasL 59 neutralizing antibody 59 EBNA1 59 NF kB pathway 59 antiandrogens 59 HUVEC 59 gastric adenocarcinoma 59 lymphangiogenesis 59 cytoplasmic domain 59 CTLs 59 VEGFR1 58 cDNAs 58 58 phosphorylated 58 pT2 58 MSH2 58 Secretase 58 isoenzymes 58 ADAMTS# 58 IGF1R 58 LHRH 58 NSCLC tumors 58 autophagic 58 Ceplene/IL-2 58 hypervascular 58 neovasculature 58 beta1 integrin 58 neoadjuvant therapy 58 MAGE A3 58 inhibitory receptor 58 neural progenitor 58 FUS1 58 leiomyomas 58 mammary cells 58 vitro 58 cytotoxin 58 Ki# 58 antiangiogenic 58 antimitotic 58 neurite outgrowth 58 IL 1ß 58 neoadjuvant chemotherapy 58 aminopeptidase 58 lysophosphatidic acid 58 mesothelial cells 58 N. gonorrhoeae 58 multiple myeloma MM 58 immunocompromised mice 58 lactate dehydrogenase 58 anti inflammatory cytokine 58 mammary tumor formation 58 karyotypes 58 transactivation 58 pituitary adenomas 58 KRAS mutant 58 HER2 amplification 58 TET2 58 CD# + [002] 58 activating mutations 58 Estrogen Receptor 58 cytotoxic 58 BRAF mutation 58 leiomyoma 58 cyclin D1 58 thioredoxin 58 estrogen receptor beta 58 nucleated cells 58 MAb 58 enzymatic activity 58 antiviral potency 58 induce apoptosis 58 labetuzumab 58 lysosomal 58 antisense inhibitors 58 annexin 58 urothelial 58 EGFR expression 58 Î ² 58 busulfan 58 lymph node metastases 58 gonadotropins 58 Sprague Dawley rats 58 cMET 58 macrophage colony stimulating 58 hematopoietic progenitors 58 biochemical assays 58 histopathological 58 umbilical vein 58 aneuploid 58 c myc 58 antitumor effect 58 EGF receptors 58 Vidofludimus 58 endometrioid 58 transgenic mouse models 58 IL2 58 pharmacodynamic PD 58 prostate cancer CaP 58 shRNA 58 liver metastases 58 cytological 58 K RAS 58 OCT4 58 mediated inhibition 58 transmembrane protein 58 parthenolide 58 clonogenic 58 peritoneal carcinomatosis 58 AGTR1 58 mRCC 58 mimetics 58 osteoclast 58 VEGF receptor 58 Pharmacokinetics PK 58 tryptase 58 isogenic 58 vascular endothelial cells 58 metastatic gastric 58 stably transfected 58 methyltransferase 58 histologic subtypes 58 chemosensitivity 58 basal cells 58 liposomal doxorubicin 58 selectively binds 58 innate immune responses 58 lymphoid organs 58 MET amplification 58 monoclonal 58 Figure 1A 58 hematoxylin 58 immunofluorescence microscopy 58 siRNA knockdown 58 factor HGF 58 μg ml 58 selective inhibition 58 AAV2 58 plasmacytoid dendritic cells 58 B7 H4 58 metabolomic profiles 58 CD# antibody [001] 58 CTGF 58 immunostimulatory 58 imatinib therapy 58 fumagillin nanoparticles 58 glutamyl 58 luteinizing hormone releasing 58 tumor specific antigen 58 Mucosal 58 CsA 58 CIN2 + 58 chlamydial 58 apical membrane 58 carcinoids 58 GLI1 58 gamma tocotrienol 58 hpSCs 58 protein tyrosine phosphatase 1B 58 myeloproliferative diseases 58 erythropoiesis 58 thyroglobulin 58 IGF IR 58 situ hybridization 58 unconjugated 58 peroxidase 58 ductal 58 receptor CD# 58 Clusterin 58 doxorubicin cyclophosphamide 58 gastric carcinoma 58 humanized monoclonal antibodies 58 myocytes 58 monoclonal antibody mAb 58 B7 H3 58 chemokine receptor 58 hypermethylation 58 NOD mouse 58 TAp# 58 F FDG PET 58 specific CD8 + 58 micronuclei 58 bactericidal activity 58 overexpressing cells 58 motoneurons 58 factor G CSF 58 ovariectomized 58 chemotherapeutic drug 58 intravesical instillation 58 hyperinsulinemic euglycemic clamp 58 epithelia 58 redox active 58 lenalidomide dexamethasone 58 neurotrophic 58 carcinomas 58 Notch1 58 radiochemotherapy 58 VEGFb 58 micrometastasis 58 NS3 58 chemoresistance 58 trastuzumab Herceptin R 58 GPx 58 Upregulation 58 ELISPOT 58 hamartoma 58 liver metastasis 58 PARP inhibition 58 MDR1 58 epithelial cell 58 Neisseria gonorrhoeae 57 renal cell carcinomas 57 p#INK#a 57 gastrointestinal stromal tumors GISTs 57 lentiviral vectors 57 multikinase inhibitor 57 HuR 57 homodimers 57 benign neoplasms 57 idiotype protein 57 c Src 57 IgG4 57 gefitinib Iressa 57 hypoxia inducible factor 57 follicular thyroid cancer 57 herpesviruses 57 invasive carcinoma 57 azacytidine 57 microglial 57 NOD mice 57 oncoprotein 57 IFN γ 57 bispecific antibodies 57 immunohistochemistry 57 orthologs 57 Interferon alfa 57 SOD1 57 57 fulvestrant 57 cell lysate 57 recombinant erythropoietin 57 PI3K inhibitor 57 papillary RCC 57 antitumor effects 57 hepatocellular carcinoma HCC 57 hormone LHRH 57 cultured cells 57 deletion mutant 57 PSMA ADC 57 humanized antibody 57 IFNg 57 cervical lymph nodes 57 endostatin 57 FKBP# 57 aneuploid cells 57 CCR1 57 HbF 57 CagA 57 leukemia CLL 57 fosbretabulin 57 lymphoid tissue 57 vivo preclinical studies 57 histologic subtype 57 TGF β 57 transferrin receptor 57 GAP #B# 57 cytokines IL 57 metastatic lesions 57 thrombopoietin 57 BMP2 57 upregulated 57 aromatase 57 cytotoxic effects 57 chemoradiotherapy 57 beta actin 57 osteoinductive 57 steroidogenesis 57 imatinib resistant 57 viral antigen 57 Etoposide 57 Fas ligand 57 humoral responses 57 MenSCs 57 antiangiogenic therapy 57 #β estradiol 57 JAK2 57 MALT lymphoma 57 somatic mutations 57 p# mitogen activated 57 catenin 57 KRAS oncogene 57 antibody conjugates 57 carcinoembryonic antigen CEA 57 virus AAV 57 glioblastoma tumors 57 antisense oligonucleotides 57 adipogenic 57 GISTs 57 HER2 overexpression 57 Schwann cell 57 transcriptional repressor 57 adriamycin 57 monocyte 57 metastatic renal cell carcinoma 57 PARP1 57 microsomal 57 folate receptor 57 CXCR4 expression 57 GPNMB 57 monoclonal anti 57 bladder tumors 57 ß catenin 57 caveolin 57 KIT mutations 57 humoral immunity 57 IgG1 antibody 57 SOX9 57 tumor biopsies 57 cell adhesion molecule 57 pancreatic islet 57 lymphoid 57 RQ PCR 57 RASSF1A 57 undifferentiated hESCs 57 myeloablative 57 geldanamycin 57 MEK1 57 Cytotoxic T 57 elacytarabine 57 overexpress 57 hamartomas 57 receptor inhibitor 57 INGN 57 mesangial 57 dimeglumine 57 dimeric 57 lung fibroblasts 57 thymocytes 57 SATB1 57 neurturin 57 LPS induced 57 potent inducer 57 scintigraphic 57 extracellular domains 57 NKG2D 57 aT cell 57 mononuclear 57 metalloprotease 57 atherosclerotic lesions 57 adenovirus vectors 57 transthyretin 57 cholangiocarcinoma 57 CD4 + T lymphocytes 57 Alkaline Phosphatase 57 eIF 4E 57 Papillary 57 PI3K Akt 57 glycosylated 57 C. albicans 57 CCX# 57 plasma pharmacokinetics 57 invasive ductal 57 EZN 57 cells PBMCs 57 S/GSK# 57 intact parathyroid hormone 57 intratumoral 57 receptor tyrosine kinase 57 immune stimulatory 57 pyrimidine 57 Monocyte 57 estrogen estradiol 57 MTHFR 57 Oncogenic 57 K ras 57 PHD2 57 Immunohistochemical 57 serine protease 57 decitabine 57 p# activation 57 gene inactivation 57 IL #E 57 HLA DR 57 phosphorylate 57 preclinically 57 receptor tyrosine kinase inhibitor 57 kDa protein 57 PAM4 57 uPA 57 vascular disrupting agents 57 L asparaginase 57 JAK2 inhibitors 57 transmembrane receptor 57 matrix metalloproteinase 57 phagocyte 57 somatostatin receptor 57 pulmonary metastasis 57 gastrin 57 granulocyte 57 endometrial 57 clinicopathological features 57 bevacizumab Avastin R 57 histone acetylation 57 FK# 57 constitutively activated 57 lentiviral vector 57 tumor necrosis 57 pyruvate kinase 57 JAK inhibitors 57 ß amyloid 57 costimulatory 57 granulosa cell 57 lung metastasis 57 CYT# potent vascular disrupting 57 BCL2 57 pleiotropic 57 Mesenchymal 57 trisomic 57 highly immunogenic 57 morphologic 57 HCV replication 57 TGF β1 57 thermosensitive 57 immune modulating 57 interferon γ 57 S#A# [002] 57 doxorubicin 57 PDGF receptor 57 C1q 57 chemotherapeutic agent 57 Bleomycin 57 situ LCIS 57 tumors GIST 57 potently inhibit 57 STAT1 57 antisense oligonucleotide 57 leukemia AML 57 TLR2 57 K ras gene 57 epithelioid 57 solithromycin 57 Akt phosphorylation 57 bFGF 57 ultrastructure 57 DNA adducts 57 mosaicism 57 myoblast 57 GSTT1 57 ZFP TF 57 kallikrein 57 Her2/neu 57 tenascin C 57 embryoid bodies 57 suppressor gene 57 mutant alleles 57 IL 1beta 56 tumor metastases 56 transient transfection 56 nucleoside analog 56 PKC delta 56 mutant p# 56 antitumoral 56 dimerization 56 estrogen receptor progesterone receptor 56 T#I mutant 56 gemcitabine Gemzar ® 56 TACE 56 topoisomerase 56 intra tumoral 56 mammary tumors 56 malignant transformation 56 lymphocyte proliferation 56 antiangiogenic activity 56 p# deficient 56 DHFR 56 beta subunit 56 Htt 56 E. faecalis 56 biotinylated 56 serous ovarian cancer 56 immunotoxins 56 IGFBP2 56 bone metastasis 56 anti apoptotic proteins 56 distant metastasis 56 neoplasia 56 CD# receptor 56 BRCA2 mutation carriers 56 membranous nephropathy 56 concurrent chemoradiation 56 humoral immune response 56 mutated K ras 56 lymphotoxin 56 colorectal liver metastases 56 cytosolic 56 CD8 responses 56 cardiac myocytes 56 adrenoceptor 56 factor PlGF 56 protein kinase inhibitor 56 bexarotene 56 S. enterica 56 Prox1 56 rHuEPO 56 Bezielle 56 mucin 56 CD# antigen 56 histologic 56 urothelial cancer 56 progesterone receptor PR 56 aberrantly activated 56 myoepithelial cells 56 metalloproteinase 56 OvaRex MAb 56 hENT1 56 AKT inhibitor 56 cDNA library 56 MMP# 56 KLF4 56 Superoxide 56 retroviral vectors 56 capsular polysaccharide 56 colony stimulating factor 56 antibody titers

Back to home page